IQVIA Holdings Inc. which can be found using ticker (IQV) now have 17 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $295.00 and $235.00 and has a mean share price target at $271.24. (at the time of writing). Now with the previous closing price of $231.18 this is indicating there is a potential upside of 17.3%. The 50 day moving average now sits at $239.43 and the 200 moving average now moves to $220.79. The total market capitalization for the company now stands at 41.92B. The stock price is currently at: $230.09 USD
The potential market cap would be $49,186,913,809 based on the market consensus.
The company has a dividend yield of 2.93%. Other points of data to note are a P/E ratio of 31.43, revenue per share of $82.42 and a 5.03% return on assets.
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.
